For: | Papadopoulou A, Papadopoulos KI. Successful lifestyle modifications may underlie umbilical cord-mesenchymal stromal cell effects in type 2 diabetes mellitus. World J Diabetes 2023; 14(3): 347-351 [PMID: 37035224 DOI: 10.4239/wjd.v14.i3.347] |
---|---|
URL: | https://www.wjgnet.com/1948-0210/full/v14/i3/347.htm |
Number | Citing Articles |
1 |
Li Jia, Na Li, Vincent van Unen, Jaap-Jan Zwaginga, Jerry Braun, Pieter Hiemstra, Frits Koning, P. Khedoe, Jan Stolk. Pulmonary and Systemic Immune Profiles Following Lung Volume Reduction Surgery and Allogeneic Mesenchymal Stromal Cell Treatment in Emphysema. Cells 2024; 13(19): 1636 doi: 10.3390/cells13191636
|
2 |
Miao Zhu, Ruifang Guan, Guo Ma. Efficacy and safety of teneligliptin in patients with type 2 diabetes mellitus: a Bayesian network meta-analysis. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1282584
|
3 |
Priyamvada Amol Arte, Kanchanlata Tungare, Mustansir Bhori, Renitta Jobby, Jyotirmoi Aich. Treatment of type 2 diabetes mellitus with stem cells and antidiabetic drugs: a dualistic and future-focused approach. Human Cell 2023; 37(1): 54 doi: 10.1007/s13577-023-01007-0
|